vs

Side-by-side financial comparison of ARVINAS, INC. (ARVN) and AST SpaceMobile, Inc. (ASTS). Click either name above to swap in a different company.

AST SpaceMobile, Inc. is the larger business by last-quarter revenue ($54.3M vs $41.9M, roughly 1.3× ARVINAS, INC.). ARVINAS, INC. runs the higher net margin — -83.8% vs -136.2%, a 52.4% gap on every dollar of revenue. On growth, AST SpaceMobile, Inc. posted the faster year-over-year revenue change (2758.2% vs -59.1%). ARVINAS, INC. produced more free cash flow last quarter ($-59.2M vs $-330.7M).

Arvinas, Inc. is a clinical-stage biotechnology company focused on developing targeted protein degradation therapies, including PROTAC molecules, to treat cancer and rare diseases. It operates primarily in the U.S. and global biopharma markets, advancing multiple pipeline candidates through clinical trials to address unmet medical needs.

AST SpaceMobile, Inc. is a publicly traded satellite designer and manufacturer based in Midland, Texas, United States. The company is building the SpaceMobile satellite constellation, a space-based cellular broadband network designed to connect directly to standard, unmodified smartphones. The network is intended to deliver 4G and 5G broadband coverage globally, particularly in remote and underserved regions.

ARVN vs ASTS — Head-to-Head

Bigger by revenue
ASTS
ASTS
1.3× larger
ASTS
$54.3M
$41.9M
ARVN
Growing faster (revenue YoY)
ASTS
ASTS
+2817.2% gap
ASTS
2758.2%
-59.1%
ARVN
Higher net margin
ARVN
ARVN
52.4% more per $
ARVN
-83.8%
-136.2%
ASTS
More free cash flow
ARVN
ARVN
$271.5M more FCF
ARVN
$-59.2M
$-330.7M
ASTS

Income Statement — Q3 FY2025 vs Q4 FY2025

Metric
ARVN
ARVN
ASTS
ASTS
Revenue
$41.9M
$54.3M
Net Profit
$-35.1M
$-74.0M
Gross Margin
Operating Margin
-104.5%
-175.0%
Net Margin
-83.8%
-136.2%
Revenue YoY
-59.1%
2758.2%
Net Profit YoY
28.7%
-106.3%
EPS (diluted)
$-0.48

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ARVN
ARVN
ASTS
ASTS
Q4 25
$54.3M
Q3 25
$41.9M
$14.7M
Q1 25
$188.8M
Q4 24
$59.2M
Q3 24
$102.4M
Q2 24
$76.5M
Q1 24
$25.3M
Q4 23
$-43.1M
$0
Net Profit
ARVN
ARVN
ASTS
ASTS
Q4 25
$-74.0M
Q3 25
$-35.1M
$-122.9M
Q1 25
$82.9M
Q4 24
$-45.1M
Q3 24
$-49.2M
Q2 24
$-35.2M
Q1 24
$-69.4M
Q4 23
$-154.8M
$-31.9M
Operating Margin
ARVN
ARVN
ASTS
ASTS
Q4 25
-175.0%
Q3 25
-104.5%
-1109.0%
Q1 25
37.8%
Q4 24
-98.1%
Q3 24
-58.9%
Q2 24
-63.4%
Q1 24
-329.2%
Q4 23
383.5%
Net Margin
ARVN
ARVN
ASTS
ASTS
Q4 25
-136.2%
Q3 25
-83.8%
-833.7%
Q1 25
43.9%
Q4 24
-76.2%
Q3 24
-48.0%
Q2 24
-46.0%
Q1 24
-274.3%
Q4 23
359.2%
EPS (diluted)
ARVN
ARVN
ASTS
ASTS
Q4 25
Q3 25
$-0.48
Q1 25
$1.14
Q4 24
$-0.63
Q3 24
$-0.68
Q2 24
$-0.49
Q1 24
$-0.97
Q4 23
$-2.65

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ARVN
ARVN
ASTS
ASTS
Cash + ST InvestmentsLiquidity on hand
$787.6M
$4.3B
Total DebtLower is stronger
$600.0K
Stockholders' EquityBook value
$564.4M
$2.4B
Total Assets
$844.3M
$5.0B
Debt / EquityLower = less leverage
0.00×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ARVN
ARVN
ASTS
ASTS
Q4 25
$4.3B
Q3 25
$787.6M
$2.4B
Q1 25
$954.3M
Q4 24
$1.0B
Q3 24
$1.1B
Q2 24
$1.2B
Q1 24
$1.2B
Q4 23
$1.3B
$155.3M
Total Debt
ARVN
ARVN
ASTS
ASTS
Q4 25
Q3 25
$600.0K
Q1 25
$700.0K
Q4 24
$800.0K
Q3 24
$800.0K
Q2 24
$900.0K
Q1 24
$900.0K
Q4 23
$1.0M
Stockholders' Equity
ARVN
ARVN
ASTS
ASTS
Q4 25
$2.4B
Q3 25
$564.4M
$1.6B
Q1 25
$660.1M
Q4 24
$561.7M
Q3 24
$586.0M
Q2 24
$600.2M
Q1 24
$609.7M
Q4 23
$660.0M
$213.6M
Total Assets
ARVN
ARVN
ASTS
ASTS
Q4 25
$5.0B
Q3 25
$844.3M
$2.6B
Q1 25
$1.0B
Q4 24
$1.1B
Q3 24
$1.2B
Q2 24
$1.3B
Q1 24
$1.2B
Q4 23
$1.3B
$360.9M
Debt / Equity
ARVN
ARVN
ASTS
ASTS
Q4 25
Q3 25
0.00×
Q1 25
0.00×
Q4 24
0.00×
Q3 24
0.00×
Q2 24
0.00×
Q1 24
0.00×
Q4 23
0.00×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ARVN
ARVN
ASTS
ASTS
Operating Cash FlowLast quarter
$-59.1M
$65.0M
Free Cash FlowOCF − Capex
$-59.2M
$-330.7M
FCF MarginFCF / Revenue
-141.3%
-609.0%
Capex IntensityCapex / Revenue
0.2%
728.7%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-361.6M
$-790.4M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ARVN
ARVN
ASTS
ASTS
Q4 25
$65.0M
Q3 25
$-59.1M
$-64.5M
Q1 25
$-88.9M
Q4 24
$-84.1M
Q3 24
$-128.0M
Q2 24
$50.3M
Q1 24
$-97.5M
Q4 23
$-83.1M
$-24.9M
Free Cash Flow
ARVN
ARVN
ASTS
ASTS
Q4 25
$-330.7M
Q3 25
$-59.2M
$-302.9M
Q1 25
$-89.3M
Q4 24
$-84.4M
Q3 24
$-128.7M
Q2 24
$49.6M
Q1 24
$-97.6M
Q4 23
$-83.2M
$-47.2M
FCF Margin
ARVN
ARVN
ASTS
ASTS
Q4 25
-609.0%
Q3 25
-141.3%
-2055.0%
Q1 25
-47.3%
Q4 24
-142.6%
Q3 24
-125.7%
Q2 24
64.8%
Q1 24
-385.8%
Q4 23
193.0%
Capex Intensity
ARVN
ARVN
ASTS
ASTS
Q4 25
728.7%
Q3 25
0.2%
1617.6%
Q1 25
0.2%
Q4 24
0.5%
Q3 24
0.7%
Q2 24
0.9%
Q1 24
0.4%
Q4 23
-0.2%
Cash Conversion
ARVN
ARVN
ASTS
ASTS
Q4 25
Q3 25
Q1 25
-1.07×
Q4 24
Q3 24
Q2 24
Q1 24
Q4 23

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ARVN
ARVN

Segment breakdown not available.

ASTS
ASTS

Products$44.4M82%
Other$7.8M14%
Sat Co$2.1M4%

Related Comparisons